We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 27, 2024 NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...
Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 1, 2024 NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.045 | -3.65853658537 | 1.23 | 1.26 | 1.17 | 107293 | 1.19761942 | CS |
4 | -0.075 | -5.95238095238 | 1.26 | 1.31 | 1.17 | 120957 | 1.25217661 | CS |
12 | -0.065 | -5.2 | 1.25 | 1.36 | 1.15 | 213753 | 1.28378813 | CS |
26 | -0.355 | -23.0519480519 | 1.54 | 1.61 | 1.01 | 280662 | 1.3208647 | CS |
52 | 0.285 | 31.6666666667 | 0.9 | 1.7 | 0.57 | 977857 | 1.28673331 | CS |
156 | -10.145 | -89.5410414828 | 11.33 | 12.005 | 0.56 | 688528 | 2.05407295 | CS |
260 | -18.795 | -94.0690690691 | 19.98 | 29.32 | 0.56 | 541665 | 5.51449555 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions